Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 5, 2017 – The FDA approved an update to the Warnings and Precautions section of the Lemtrada (alemtuzumab) drug label regarding the risk of acute acalculous cholecystitis.
Return to publications